Evidence map›Paper›PMID 40297168›Full record

ReviewMDM policy & practice

Characterizing the Design of and Emerging Evidence for Health Care Organization-Based Lung Cancer Screening Interventions: A Systematic Review.

Jennifer Elston Lafata, Katharine A Rendle, Jocelyn V Wainwright, Mary E Cooley, Anil Vachani, Christine Neslund-Dudas, Michelle R Odelberg, Liana Alcaro, Claire Staresinic, Gwen L Alexander and 2 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in MDM policy & practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Updates in Lung Cancer Screening: A Decade of Evidence.Seminars in respiratory and critical care medicine · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jennifer Elston LafataUNC Eshelman School of Pharmacy and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.ORCID https://orcid.org/0000-0002-8550-6195
Katharine A RendleDepartment of Family Medicine & Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-7761-8728
Jocelyn V WainwrightDepartment of Family Medicine & Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0003-0685-6021
Mary E CooleyDana-Farber Cancer Institute/Harvard Cancer Center, Boston, MA, USA.
Anil VachaniDepartment of Medicine, Division of Pulmonary, Allergy and Critical Care, University of Pennsylvania, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-3871-8697
Christine Neslund-DudasDepartment of Public Health Sciences, Henry Ford Health, Detroit, MI, USA.
Michelle R OdelbergInstitute for Health Research, Kaiser Permanente Colorado, Aurora, CO, USA.
Liana AlcaroDepartment of Family Medicine & Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Claire StaresinicUNC Eshelman School of Pharmacy and UNC Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Gwen L AlexanderDepartment of Public Health Sciences, Henry Ford Health, Detroit, MI, USA.
Rebecca B CarlsonUNC Eshelman School of Pharmacy and Health Sciences Library, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Marilyn M SchapiraDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID https://orcid.org/0000-0002-3775-9462

Funding

Center for Research to Optimize Precision Lung Cancer Screening in Diverse PopulationsUM1CA221939 · NCI · KAISER FOUNDATION RESEARCH INSTITUTE · PI RITZWOLLER, DEBRA P, VACHANI, ANIL · 2018 to 2023
$15.3M
NCI NIH HHS UM1 CA221939
6 · The paper itself

Abstract

Highlights: Most lung cancer screening (LCS) interventions evaluated to date have been educational in nature and focused primarily on shared decision making or the initial uptake of screening, with some interventions demonstrating statistically significant improvements in patient knowledge and initial LCS order/uptake.A critical gap in knowledge remains regarding how to effectively support LCS eligibility assessment as well as adherence to annual screening and appropriate diagnostic testing.Findings underscore the need for the field to expand beyond education-focused interventions and incorporate multilevel targets when designing interventions to support high-quality LCS in practice.

Indexed as

adherencecancer screeningcomplianceeducationeligibilityevidence-based medicineguidelineshealth behaviorlung cancerrisk assessmentshared decision making

Identifiers

PMID40297168
PMCPMC12035285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.